Foamix Pharmaceuticals Ltd. EBITDA Margin 2016-2019 | FOMX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Foamix Pharmaceuticals Ltd. (FOMX) over the last 10 years. The current EBITDA margin for Foamix Pharmaceuticals Ltd. as of September 30, 2019 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2019-03-31 | $0.00B | $-0.07B | -2200.00% |
| 2018-12-31 | $0.00B | $-0.08B | -1900.00% |
| 2018-09-30 | $0.00B | $-0.08B | -1950.00% |
| 2018-06-30 | $0.00B | $-0.08B | -2000.00% |
| 2018-03-31 | $0.00B | $-0.08B | -1950.00% |
| 2017-12-31 | $0.00B | $-0.07B | -1675.00% |
| 2017-09-30 | $0.00B | $-0.06B | -1525.00% |
| 2017-06-30 | $0.01B | $-0.05B | -816.67% |
| 2017-03-31 | $0.01B | $-0.04B | -666.67% |
| 2016-12-31 | $0.01B | $-0.03B | -500.00% |
| 2016-09-30 | $0.01B | $-0.03B | -500.00% |
| 2016-06-30 | $0.00B | $-0.02B | -1150.00% |
| 2016-03-31 | $0.00B | $-0.02B | -2000.00% |
| 2015-12-31 | $0.00B | $-0.02B | inf% |
